Great West Life Assurance CO Catalyst Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 133,207 shares of CPRX stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,207

Previous 137,214 2.92%

Holding current value

$2.93 Million

Previous $2.73 Million 1.87%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	SELL	$19.73 - $23.93 $79,058 - $95,887	-4,007 Reduced 2.92%	133,207 $2.78 Million
Q3 2024 Nov 13, 2024	SELL	$15.19 - $21.35 $56,582 - $79,528	-3,725 Reduced 2.64%	137,214 $2.73 Million
Q2 2024 Aug 12, 2024	SELL	$14.68 - $16.92 $92,572 - $106,697	-6,306 Reduced 4.28%	140,939 $2.18 Million
Q1 2024 May 13, 2024	BUY	$13.18 - $17.11 $218,774 - $284,008	16,599 Added 12.71%	147,245 $2.35 Million
Q4 2023 Feb 13, 2024	SELL	$11.78 - $17.29 $99,988 - $146,757	-8,488 Reduced 6.1%	130,646 $2.19 Million
Q3 2023 Nov 14, 2023	BUY	$11.69 - $15.02 $97,588 - $125,386	8,348 Added 6.38%	139,134 $1.62 Million
Q2 2023 Aug 10, 2023	SELL	$11.5 - $18.08 $49,760 - $78,232	-4,327 Reduced 3.2%	130,786 $1.76 Million
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $136,674 - $200,627	-9,531 Reduced 6.59%	135,113 $2.24 Million
Q4 2022 Feb 10, 2023	BUY	$12.25 - $19.5 $265,469 - $422,584	21,671 Added 17.62%	144,644 $2.7 Million
Q3 2022 Nov 01, 2022	BUY	$7.06 - $15.52 $868,189 - $1.91 Million	122,973 New	122,973 $1.58 Million
Q3 2020 Nov 17, 2020	BUY	$2.97 - $5.08 $8,595 - $14,701	2,894 Added 114.3%	5,426 $16,000
Q3 2020 Nov 13, 2020	SELL	$2.97 - $5.08 $8,595 - $14,701	-2,894 Reduced 53.34%	2,532 $7,000
Q4 2019 Feb 11, 2020	BUY	$3.67 - $5.7 $19,913 - $30,928	5,426 New	5,426 $20,000
Q3 2019 Oct 25, 2019	SELL	$3.89 - $7.43 $39,783 - $75,986	-10,227 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$2.7 - $6.11 $27,612 - $62,486	10,227 New	10,227 $0

Others Institutions Holding CPRX

# of Institutions

348

Shares Held

98.5M

Call Options Held

13.4K

Put Options Held

11.7K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.26B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Catalyst Pharmaceuticals, Inc. Transaction History